Royalty Rate. Licensee shall pay to Licensor three percent (3%) of the first $25 million of Revenues received by Licensee or its Affiliates, and two percent (2%) of all additional Revenues received by Licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 and 4.2.3.
Appears in 5 contracts
Samples: Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.), Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.), License Agreement (VistaGen Therapeutics, Inc.)
Royalty Rate. Licensee shall pay to Licensor three percent (3%) of the first $25 million of cumulative Revenues received by Licensee or its Its Affiliates, and two percent (2%) of all additional cumulative Revenues received by Licensee licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 4.2.4 and 4.2.3.4.2.S.
Appears in 2 contracts
Samples: Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.), Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.)
Royalty Rate. Licensee shall pay to Licensor three percent (3%) of the first $US$25 million of cumulative Revenues received by Licensee or its Affiliates, and two percent (2%) of all additional cumulative Revenues received by Licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 4.2.4 and 4.2.34.2.5.
Appears in 2 contracts
Samples: Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.), Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.)
Royalty Rate. Licensee shall pay to Licensor three percent (3%) of the first $25 million of Revenues received by Licensee or its Affiliates, and two percent (2%) of all additional Revenues received by Licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 and 4.2.3.. 4.2.2
Appears in 1 contract
Samples: License Agreement